Astellas Pharma, Inc. (ALPMF)
Astellas Pharma Market Cap: 23.91B for Jan. 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 50.78B |
| Nxera Pharma Co., Ltd. | 466.05M |
| PeptiDream Inc. | 1.389B |
| Stemcell Holdings, Inc. | 60.00M |
Market Cap Related Metrics
| PE Ratio | 27.91 |
| PS Ratio | 1.779 |
| PEG Ratio | 0.1965 |
| Price to Book Value | 2.190 |
| Price to Free Cash Flow | 10.51 |
| Price | 13.35 |
| Earnings Yield | 3.58% |
| PEGY Ratio | 0.1914 |
| Operating PE Ratio | 9.906 |
| Normalized PE Ratio | 27.91 |